Company & Sponsor Intelligence
National Institute of Mental Health (NIMH)
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials32
Recruiting6
Completed18
Countries1
Therapeutic footprint
adhdalzheimersanxietyautismdepressionepilepsyother_neurologyother_psychiatryparkinsonsschizophrenia
Indexed studies
NCT01339767Study of Toddlers With Language Delay
autism · United StatesCOMPLETED
autism · United StatesCOMPLETED
NCT03958630PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand
alzheimers · United StatesPHASE1
alzheimers · United StatesPHASE1
NCT00001192Neuropsychological Evaluation of Psychiatric and Neurological Patients
epilepsy · United StatesCOMPLETED
epilepsy · United StatesCOMPLETED
NCT00012584Treatment of Youth With ADHD and Anxiety
adhd · United StatesNA
adhd · United StatesNA
NCT01867398Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct Disorders
schizophrenia · United StatesTERMINATED
schizophrenia · United StatesTERMINATED
NCT04396873PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
alzheimers · United StatesPHASE1
alzheimers · United StatesPHASE1
NCT00527579PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB
epilepsy · United StatesPHASE1
epilepsy · United StatesPHASE1
NCT02247986Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
adhd · PHASE1, PHASE2
adhd · PHASE1, PHASE2
NCT00113022Org 24448 to Treat Major Depression
depression · United StatesPHASE2
depression · United StatesPHASE2
NCT05608434Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
adhd · United StatesPHASE1, PHASE2
adhd · United StatesPHASE1, PHASE2
NCT00015548CATIE-Alzheimer's Disease Trial
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT00526916PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28
epilepsy · United StatesPHASE1
epilepsy · United StatesPHASE1
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →